BACKGROUND: Tuberculosis is a large source of morbidity and mortality among children. However, limited studies characterize childhood tuberculosis disease, and contact investigation is rarely implemented in high-burden settings. In one of the largest pediatric tuberculosis contact investigation studies in a resource-limited setting, we assessed the yield of contact tracing on childhood tuberculosis and indicators for disease progression in Uganda. METHODS: Child contacts aged <15 years in Kampala, Uganda, were enrolled from July 2002 to June 2009 and evaluated for tuberculosis disease via clinical, radiographic, and laboratory methods for up to 24 months. RESULTS: Seven hundred sixty-one child contacts were included in the analysis. Prevalence of tuberculosis in our child population was 10%, of which 71% were culture-confirmed positive. There were no cases of disseminated tuberculosis, and 483 of 490 children (99%) started on isoniazid preventative therapy did not develop disease. Multivariable testing suggested risk factors including human immunodeficiency virus (HIV) status (odds ratio [OR], 7.90; P < .001), and baseline positive tuberculin skin test (OR, 2.21; P = .03); BCG vaccination was particularly protective, especially among children aged ≤5 years (OR, 0.23; P < .001). Adult index characteristics such as sex, HIV status, and extent or severity of disease were not associated with childhood disease. CONCLUSIONS: Contact tracing for children in high-burden settings is able to identify a large percentage of culture-confirmed positive tuberculosis cases before dissemination of disease, while suggesting factors for disease progression to identify who may benefit from targeted screening.
BACKGROUND:Tuberculosis is a large source of morbidity and mortality among children. However, limited studies characterize childhood tuberculosis disease, and contact investigation is rarely implemented in high-burden settings. In one of the largest pediatric tuberculosis contact investigation studies in a resource-limited setting, we assessed the yield of contact tracing on childhood tuberculosis and indicators for disease progression in Uganda. METHODS:Child contacts aged <15 years in Kampala, Uganda, were enrolled from July 2002 to June 2009 and evaluated for tuberculosis disease via clinical, radiographic, and laboratory methods for up to 24 months. RESULTS: Seven hundred sixty-one child contacts were included in the analysis. Prevalence of tuberculosis in our child population was 10%, of which 71% were culture-confirmed positive. There were no cases of disseminated tuberculosis, and 483 of 490 children (99%) started on isoniazid preventative therapy did not develop disease. Multivariable testing suggested risk factors including human immunodeficiency virus (HIV) status (odds ratio [OR], 7.90; P < .001), and baseline positive tuberculin skin test (OR, 2.21; P = .03); BCG vaccination was particularly protective, especially among children aged ≤5 years (OR, 0.23; P < .001). Adult index characteristics such as sex, HIV status, and extent or severity of disease were not associated with childhood disease. CONCLUSIONS: Contact tracing for children in high-burden settings is able to identify a large percentage of culture-confirmed positive tuberculosis cases before dissemination of disease, while suggesting factors for disease progression to identify who may benefit from targeted screening.
Authors: Rose Ann Murray; Nazma Mansoor; Ryhor Harbacheuski; Jorge Soler; Virginia Davids; Andreia Soares; Anthony Hawkridge; Gregory D Hussey; Holden Maecker; Gilla Kaplan; Willem A Hanekom Journal: J Immunol Date: 2006-10-15 Impact factor: 5.422
Authors: R Zachariah; M P Spielmann; A D Harries; P Gomani; S M Graham; E Bakali; P Humblet Journal: Int J Tuberc Lung Dis Date: 2003-11 Impact factor: 2.373
Authors: Christian Lienhardt; Jackson Sillah; Katherine Fielding; Simon Donkor; Kebba Manneh; David Warndorff; Steve Bennett; Keith McAdam Journal: Pediatrics Date: 2003-05 Impact factor: 7.124
Authors: B J Marais; R P Gie; H S Schaaf; A C Hesseling; C C Obihara; J J Starke; D A Enarson; P R Donald; N Beyers Journal: Int J Tuberc Lung Dis Date: 2004-04 Impact factor: 2.373
Authors: Mercedes de Onis; Adelheid W Onyango; Elaine Borghi; Amani Siyam; Chizuru Nishida; Jonathan Siekmann Journal: Bull World Health Organ Date: 2007-09 Impact factor: 9.408
Authors: Ben J Marais; Robert P Gie; Anneke C Hesseling; H Simon Schaaf; Donald A Enarson; Nulda Beyers Journal: Pediatr Infect Dis J Date: 2006-03 Impact factor: 2.129
Authors: Mary Horlick; Stephen M Arpadi; James Bethel; Jack Wang; Jack Moye; Patricia Cuff; Richard N Pierson; Donald Kotler Journal: Am J Clin Nutr Date: 2002-11 Impact factor: 7.045
Authors: Catherine M Stein; Sarah Zalwango; LaShaunda L Malone; Bonnie Thiel; Ezekiel Mupere; Mary Nsereko; Brenda Okware; Hussein Kisingo; Christina L Lancioni; Charles M Bark; Christopher C Whalen; Moses L Joloba; W Henry Boom; Harriet Mayanja-Kizza Journal: Am J Epidemiol Date: 2018-07-01 Impact factor: 4.897
Authors: Leonardo Martinez; Ye Shen; Andreas Handel; Srijita Chakraburty; Catherine M Stein; LaShaunda L Malone; W Henry Boom; Frederick D Quinn; Moses L Joloba; Christopher C Whalen; Sarah Zalwango Journal: Lancet Respir Med Date: 2017-12-19 Impact factor: 30.700
Authors: Leonardo Martinez; Andreas Handel; Ye Shen; Srijita Chakraburty; Frederick D Quinn; Catherine M Stein; LaShaunda L Malone; Sarah Zalwango; Christopher C Whalen Journal: Am J Respir Crit Care Med Date: 2018-05-01 Impact factor: 21.405
Authors: S Zawedde-Muyanja; A Nakanwagi; J P Dongo; M P Sekadde; R Nyinoburyo; G Ssentongo; A K Detjen; F Mugabe; J Nakawesi; Y Karamagi; P Amuge; A Kekitiinwa; S M Graham Journal: Int J Tuberc Lung Dis Date: 2018-11-01 Impact factor: 2.373
Authors: Carina Marquez; Gabriel Chamie; Jane Achan; Anne F Luetkemeyer; Mary Kyohere; Jaffer Okiring; Grant Dorsey; Moses R Kamya; Edwin D Charlebois; Diane V Havlir Journal: Pediatr Infect Dis J Date: 2016-05 Impact factor: 2.129
Authors: Stephen M Graham; Luis E Cuevas; Patrick Jean-Philippe; Renee Browning; Martina Casenghi; Anne K Detjen; Devasena Gnanashanmugam; Anneke C Hesseling; Beate Kampmann; Anna Mandalakas; Ben J Marais; Marco Schito; Hans M L Spiegel; Jeffrey R Starke; Carol Worrell; Heather J Zar Journal: Clin Infect Dis Date: 2015-10-15 Impact factor: 9.079
Authors: John Paul Dongo; Stephen M Graham; Joseph Nsonga; Fred Wabwire-Mangen; Elizabeth Maleche-Obimbo; Ezekiel Mupere; Rodrigo Nyinoburyo; Jane Nakawesi; Gerald Sentongo; Pauline Amuge; Anne Detjen; Frank Mugabe; Stavia Turyahabwe; Moorine P Sekadde; Stella Zawedde-Muyanja Journal: Trop Med Infect Dis Date: 2021-07-14